• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS W/SA 25 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS W/SA 25 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV435T
Device Problems Obstruction of Flow (2423); Structural Problem (2506)
Patient Problems Failure of Implant (1924); Patient Problem/Medical Problem (2688)
Event Date 02/28/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported that po limited adjustment of valve.The explanted product were delivered to miethke with the return kit inside an unknown liquid.The file is entered with limited information.
 
Manufacturer Narrative
Investigation visual inspection scratches on the outer housing of the valve were observed through the visual inspection.No significant deformations or damage was detected.Permeability test a permeability test has shown that progav valve is permeable.Adjustment test the progav 2.0 valve was tested and is not adjustable through out the normal range.Braking force and brake function test.The brake functionality test has shown that the brake function is operational; however, the braking force cannot be measured due to the non-adjustability of the valve.We have dismantled the valves.Inside both valves, we have found slight build-up of substances (likely protein).Based on our investigation, we confirm the valve is non-adjustable, likely due to deposits observed inside the valves.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV SYS W/SA 25 A.CONTROL RESERVOIR
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8418689
MDR Text Key138754864
Report Number3004721439-2019-00072
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 11/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/13/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFV435T
Device Catalogue NumberFV435T
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/05/2019
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/08/2019
Date Manufacturer Received03/18/2019
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-